Literature DB >> 5096082

Evidence for a terminal -D-galactopyranosyl residue in galactosylgalactosylglucosylceramide from human kidney.

J T Clarke, L S Wolfe, A S Perlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5096082

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  6 in total

1.  Building a cathedral: neuroscience and the legacy of Leon Wolfe.

Authors:  Matthew W Spence
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

Review 2.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

3.  Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells.

Authors:  D Miyamoto; T Ueno; S Takashima; K Ohta; T Miyawaki; T Suzuki; Y Suzuki
Journal:  Glycoconj J       Date:  1997-04       Impact factor: 2.916

4.  [Analytical study of Fabry's disease (author's transl)].

Authors:  J Roth; E Schulze; G Raabe; G Waldmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

5.  Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection.

Authors:  T Suzuki; A Sometani; Y Yamazaki; G Horiike; Y Mizutani; H Masuda; M Yamada; H Tahara; G Xu; D Miyamoto; N Oku; S Okada; M Kiso; A Hasegawa; T Ito; Y Kawaoka; Y Suzuki
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

Review 6.  Enzyme replacement therapy of Fabry disease.

Authors:  Joe T R Clarke; R Mark Iwanochko
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.